New Alzheimer's drug slows disease by a third

New Alzheimer's drug slows disease by a third We could be entering the era of Alzheimer's treatments, after the second drug in under a year has been shown to slow the disease.

Experts said we were now "on the cusp" of drugs being available, something that had recently seemed "impossible".

The company Eli Lilly has reported its drug - donanemab - slows the pace of Alzheimer's by about a third.

However two volunteers, and possibly a third, died as a result of dangerous swelling in the brain. BBC News

See also:

• Donanemab Significantly Slowed Cognitive and Functional Decline in Phase 3 Study of Early Alzheimer's Disease Eli Lilly
• New Alzheimer’s drug slows cognitive decline by 35%, trial results show The Guardian
• 'The Beginning Of The End' For Alzheimer’s? Experts Hail New Drug Huffington Post UK
• World ‘on cusp of first generation of treatments for Alzheimer’s’ as new drug ‘slows symptoms’ The Independent
• Alzheimer's: New drug can reduce disease symptoms by up to 35% Sky News